There is a new study that shows that one well-known over-the-counter medicine, in particular, has been found effective in limiting the spread of COVID-19.
That’s right. People who normally utilize a low-dose aspirin regimen because they are at risk for heart attack or stroke or blood-clotting issues should also take baby aspirin to help them ward off COVID-19 as well.
One physician added, “Aspirin is low-cost, easily accessible, and people are already using it to treat their health conditions. Finding this association is a huge win for those looking to reduce risk from some of the most devastating effects of COVID-19.
“This isn’t the only study that has professed that there are plenty of possible benefits of low-dose aspirin in COVID-19 patients. Earlier this month, Medical Express wrote a report that expounded on researchers from the University of Minnesota and Basel University in Switzerland that came to the same conclusion.
The researcher’s findings were published in Lancet’s Open Access eClinical Medicine journal and it detailed how patients on these blood thinners before getting COVID-19 were actually less likely to be admitted to the hospital despite being older and having more chronic medical conditions. The findings revealed that blood thinners reduced death from COVID by nearly half. Moreover, it didn’t matter whether they were started before or after the advent of the COVID-19 infection.
As lead author of the report, Sameh Hozayen noted, “We know that COVID-19 causes blood clots that can kill patients. But, do blood thinners save lives in COVID-19? Blood thinners are medications prescribed to prevent blood clots in patients with a prior blood clot in their lungs or legs. They also prevent blood clots in the brain secondary to abnormal heart rhythms, like atrial fibrillation. Blood thinners are the standard of treatment in these diseases, which is why we looked at data to see if it impacted hospitalizations related to COVID-19.”
“We already know that overwhelmed hospitals have a higher risk for death among their patients, so reducing hospitalization may have a positive impact during a COVID-19 surge,” Hozayen added.
“Unfortunately, about half of patients who are being prescribed blood thinners for blood clots in their legs, lungs, abnormal heart rhythms or other reasons, do not take them,” Hozayen continued. “By increasing adherence for people already prescribed blood thinners, we can potentially reduce the bad effects of COVID-19.”
I have a sneaking suspicion that this isn’t going to be picked up by the mainstream media, but I digress.
